(Hypertension. 1995;26:369-373.)
© 1995 American Heart Association, Inc.
Articles |
From the Division of Cardiology, Department of Medicine, The New York HospitalCornell Medical Center, NY.
| Abstract |
|---|
|
|
|---|
Key Words: carotid arteries hypertension, arterial hypertrophy atherosclerosis ultrasonography
| Introduction |
|---|
|
|
|---|
Preliminary data suggest that vascular hypertrophy might occur earlier and/or be more prevalent than cardiac hypertrophy in hypertension. In a previous study we detected left ventricular (LV) hypertrophy in 14% of otherwise healthy hypertensive subjects, whereas vascular hypertrophy (defined as a common carotid artery intimal-medial thickness of >0.96 mm [above the 95th percentile of a matched control population]) was present in 28%.1 In addition, an increased augmentation index, reflecting at least in part increased arterial stiffness, is associated with higher LV mass in healthy subjects, independent of age, sex, and blood pressure, suggesting that vascular stiffness might precede and contribute to the development of LV hypertrophy.8 The major effect of aging on vessel wall thickness1 3 7 9 suggests that a single cut point to define normality might underestimate the prevalence of arterial hypertrophy in younger individuals and overstate its occurrence in older individuals. Therefore, we designed the present study to examine the determinants of common carotid artery size in normotensive adults to more accurately define normal relations and thereby the presence of hypertrophy in hypertension.
| Methods |
|---|
|
|
|---|
140/90 mm Hg), 36 (21%) had
borderline or white coat hypertension,11 and 9 (5%) had
isolated systolic hypertension (systolic pressure
160 mm Hg and
diastolic pressure <90 mm Hg). Thirty-nine percent of
hypertensive subjects had never received pharmacological therapy; the
remaining subjects were studied after medications had been discontinued
for from 3 weeks to 5 years. We analyzed an expanded population
of 305 (including the 172 study subjects) healthy normotensive subjects
(mean age, 48±12 years; range, 24 to 88 years) to establish normal
limits for common carotid arterial size taking into account
effects of age and body size. Subjects were studied under protocols
approved by the Committee on Human Rights in Research of Cornell
University Medical College.
Ultrasound Studies
All subjects underwent standard M-mode and two-dimensional
echocardiographic examination performed by a highly
skilled research technician using commercially available equipment.
Two-dimensionally guided M-mode tracings were coded and read blindly by
a single observer; measurements were made on up to six cycles with the
use of a digitizing tablet and were averaged. Wall thicknesses and
chamber dimensions were taken according to the American Society of
Echocardiography recommendations12 13 ;
LV mass was calculated with the use of the Penn
convention14 and adjusted for body surface area. LV
hypertrophy was considered present if LV mass index was
greater than or equal to 125 g/m2 in men or greater than or
equal to 110 g/m2 in women.15 16
Carotid ultrasonography was performed as previously
described.1 In brief, using a 7.5-MHz duplex transducer,
we scanned the extracranial carotid arteries from multiple approaches
to detect the presence of discrete
atherosclerosis.17 Two-dimensionally
guided M-mode tracings of the distal common carotid artery
approximately 1 cm proximal to the bulb were recorded on videotape
and subsequently acquired and digitized in real time with a
frame-grabber. The intimal-medial thickness of the far wall
(IMTd) and internal diameter (Dd) of the artery
at end diastole (minimum diameter) were measured with
electronic calipers on several cycles and averaged.
Arterial size was further characterized by calculating
cross-sectional area according to the formula
[IMTd+(Dd/2)]2-
[(Dd/2)]2.
Arterial relative wall thickness was calculated as
IMTd/(Dd/2). The accuracy and
reproducibility of ultrasound measurement of the carotid artery have
been previously demonstrated.1 2 7 18
Data Analysis
Data were stored on a personal computer and analyzed
with the CRUNCH4 statistical package (Crunch Software
Corp). Mean values were compared with Student's t test and
are presented with the SD as the index of dispersion. Relations
between continuous variables were evaluated by linear regression.
Independence of association was assessed by multiple stepwise
regression. Differences in prevalences between two groups were compared
by
2 analysis.
| Results |
|---|
|
|
|---|
LV absolute and relative wall thicknesses, end-diastolic diameter, mass, and mass index were significantly increased in hypertensive subjects compared with normotensive control subjects (Table 1). Common carotid artery wall thickness, end-diastolic diameter, and cross-sectional area were likewise increased on average in the hypertensive group. Although the average increases in vessel diameter and wall thickness were similar, the variability of relative wall thickness was higher and did not differ between the two groups.
|
Ventricular and Vascular
Hypertrophy
In the expanded population of 305 healthy normotensive
subjects, common carotid artery intimal-medial thickness and
cross-sectional area were related to age (r=.40 and .38,
respectively; P<.0001 for both comparisons), systolic
pressure (r=.38 and .41, respectively; P<.0001
for both), and body surface area (r=.15, P<.01
and r=.26, P<.0001, respectively). The multiple
regression equation predicting intimal-medial thickness was
IMTd=0.00586 Age+0.015267 Body Surface Area+0.16569 and
that for diastolic cross-sectional area was
CSAd=0.15669 Age+6.56617 Body Surface Area-5.4103. Blood
pressure was not included in the equations because the goal of the
study was to determine the effect of hypertension on vascular size. The
ratios of observed to predicted IMTd and CSAd
were calculated for each subject. Arterial
hypertrophy was identified in the age- and sex-matched
population if the ratio of observed/predicted dimension exceeded 2 SD
above the mean ratio in the large control population.
Prevalences of both LV and arterial hypertrophy were 5.2% among the normotensive subjects and similarly increased in the hypertensive group (LV hypertrophy in 12.2% and arterial hypertrophy in 11%) (Fig 1). Among the hypertensive subjects with LV hypertrophy, arterial hypertrophy was present in 24%, whereas arterial hypertrophy was present in only 9% of hypertensive subjects without LV hypertrophy (P<.05) (Fig 2). Discrete carotid atherosclerosis (plaque) was present in 24% of subjects and was associated with an increased LV mass (170 versus 156 g, P<.01) and mass index (88.7 versus 82.7 g/m2, P<.01) after adjustment for differences in age and blood pressure.
|
|
Determinants of LV and Carotid Artery Structure in
Hypertension
Among hypertensive subjects common carotid intimal-medial
thickness and cross-sectional area were most strongly related to age
and blood pressure (Table 2). The relation of these
measures to body size was stronger in multivariate than
in univariate analyses. In contrast, both LV wall
thickness and mass were most strongly related to body surface area and
systolic pressure, with little or no relationship to age. Common
carotid artery relative wall thickness was related only to increasing
age (r=.20, P<.01), and LV relative wall
thickness tended to increase with age (r=.15,
P=.06). Carotid cross-sectional area was also related to LV
mass (r=.33, P<.00005). Carotid artery wall
thickness (0.79±0.17 versus 0.84±0.20 mm), cross-sectional area
(16.4±5.2 versus 17.6±5.4 mm2), and LV mass (166±37
versus 171±52 g) did not significantly differ between never-treated
and previously treated hypertensive subjects.
|
| Discussion |
|---|
|
|
|---|
Although previous studies comparing common carotid artery structure in matched hypertensive and normotensive groups have uniformly detected a substantial (7% to 27%) increase in vessel wall thickness attributable to hypertension,1 2 3 4 5 6 findings with regard to diastolic luminal diameter have been variable, with some studies reporting no difference in diameter.2 3 6 We used cross-sectional area rather than diastolic diameter as a primary measure of vascular size because it incorporates changes in both vessel wall thickness and diameter and is conceptually comparable to LV mass as a measure of vascular size. In the current study the proportional increases in wall thickness and diastolic diameter in hypertensive subjects were similar (6%), whereas the increase in cross-sectional area was higher (11%). The smaller but significant increase in intimal-medial thickness noted in this study compared with earlier studies likely represents the substantially larger current study population. The lower prevalence of vascular hypertrophy in hypertension noted in the current study compared with our previous report1 likely reflects the different definition of vascular hypertrophy. However, the major effect of age on common carotid intimal-medial thickness and cross-sectional area in both hypertensive and normotensive subjects noted in this and previous studies3 9 strongly suggests that this variable should be considered in defining normality in a manner similar to body size being considered for interindividual differences in LV mass.
There have been few previous attempts to establish definitions of vascular hypertrophy, particularly with the use of methods that take into account differences in age, body size, sex, or race. Furthermore, the extent to which intimal-medial thickening represents hypertrophy as opposed to "early atherosclerosis" is uncertain and may vary depending on individual and population characteristics.17 19 Intimal-medial thicknesses greater than 1.0 mm in the common carotid artery or greater than 1.2 mm in the carotid bulb have been proposed as measures of "intimal-medial thickening" that is considered more likely to represent diffuse atherosclerosis than hypertrophy based on an association of these values with increased serum low-density lipoprotein cholesterol levels but not with hypertension.20 We previously used 0.96 mm as the upper normal limit for common carotid intimal-medial thickness (95th percentile of a control population) and found carotid hypertrophy in 28% of 43 otherwise healthy hypertensive subjects.1 Bonithon-Kopp et al21 defined common carotid arterial hypertrophy as the presence of intimal-medial thickness greater than 0.80 mm, which represents 1 SD above the mean of 717 men and women between the ages of 60 and 69 years, 19% of whom were taking lipid-lowering drugs. A more comprehensive attempt to quantify carotid artery hypertrophy has been made by the Atherosclerosis Risk in Communities (ARIC) study by developing nomograms based on race and sex relating thicknesses of various carotid artery segments to age.9 The present study, albeit smaller than the two cited above,9 21 has the advantage of using well-characterized, asymptomatic, unmedicated normotensive individuals in the control population. Girerd et al7 defined hypertrophy of the radial artery as a wall thickness greater than 0.244 mm, a value representing the 95th percentile in 40 normotensive subjects, and found hypertrophy to be present in 91% of 33 never-treated hypertensive subjects but in only 22% of 27 treated hypertensive subjects.
The extent to which previous pharmacological therapy in a substantial percentage of the hypertensive subjects influences our results is uncertain. Although most classes of antihypertensive agents22 and sodium restriction23 may reduce LV mass, the duration of this potential effect after cessation of therapy is unknown. Although a recent study has demonstrated thinner walls of the muscular radial artery in treated compared with untreated hypertensive patients7 and isradipine treatment has reduced carotid artery wall thickness in hypertensive and normotensive rats,24 we are not aware of comparable data in humans. Were such a reduction to occur and persist after cessation of therapy, one might predict that our study has underestimated the absolute prevalences of ventricular and vascular hypertrophy in hypertension, although the relative prevalences might remain similar. However, the finding that neither ventricular nor vascular size varied significantly between never-treated and previously treated hypertensive subjects suggests that previous pharmacological therapy had a negligible effect on the study results. An additional methodological consideration, ie, the healthy and asymptomatic status of our hypertensive subjects, is likely the most important factor governing the prevalences of hypertrophy in the present study.
In conclusion, significant differences in common carotid artery intimal-medial thickness, diastolic diameter, and cross-sectional area exist in hypertension. In both normotensive and hypertensive subjects vascular structure is most strongly related to the aging process, whereas LV structure is most strongly related to body size. When these relations are considered in defining hypertrophy, LV and vascular hypertrophy are similarly prevalent. Although increasing carotid intimal-medial thickness has been shown to independently predict subsequent myocardial infarction in Finnish men,25 the prognostic significance of vascular hypertrophy per se, either additive to or independent of LV hypertrophy, remains to be defined.
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
2.
Gariepy J, Massonneau M, Levenson J, Heudes D, Simon
A. Evidence for in vivo carotid and femoral wall thickening in
human hypertension. Hypertension. 1993;22:111-118.
3. Hughes AD, Sinclair A-M, Geroulakos G, Mayet J, Mackay J, Shahi M, Thom S, Nicolaides A, Sever PS. Structural changes in the heart and carotid arteries associated with hypertension in humans. J Hum Hypertens. 1993;7:395-397. [Medline] [Order article via Infotrieve]
4.
Bots ML, Hofman A, de Bruyn AM, de Jong PTVM, Grobbee
DE. Isolated systolic hypertension and vessel wall thickness of
the carotid artery: The Rotterdam Elderly Study.
Arterioscler Thromb. 1993;13:64-69.
5.
Suurküla M, Agewall S, Fagerberg B, Wendelhag I,
Widgren B, Wikstrand J. Ultrasound evaluation of atherosclerotic
manifestations in the carotid artery in high-risk hypertensive
patients. Arterioscler Thromb. 1994;14:1297-1304.
6.
Ferrara LA, Mancini M, Celentano A, Galderisi M,
Iannuzzi R, Marotta T, Gaeta I. Early changes of the
arterial carotid wall in uncomplicated primary hypertensive
patients: study by ultrasound high-resolution B-mode imaging.
Arterioscler Thromb. 1994;14:1290-1296.
7. Girerd X, Mourad J-J, Copie X, Moulin C, Acar C, Safar M, Laurent S. Noninvasive detection of an increased vascular mass in untreated hypertensive patients. Am J Hypertens. 1994;7:1076-1084. [Medline] [Order article via Infotrieve]
8. Saba PS, Roman MJ, Pini R, Spitzer M, Ganau A, Devereux RB. Relation of arterial pressure waveform to left ventricular and carotid anatomy in normotensive subjects. J Am Coll Cardiol. 1993;22:1873-1880. [Abstract]
9.
Howard G, Sharrett AR, Heiss G, Evans GW, Chambliss
LE, Riley WA, Burke GL. Carotid artery intimal-medial thickness
distribution in general populations as evaluated by B-mode
ultrasound. Stroke. 1993;24:1297-1304.
10. Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB. Association of carotid atherosclerosis and left ventricular hypertrophy. J Am Coll Cardiol. 1995;25:83-90. [Abstract]
11.
Pickering TG, James GD, Boddie C, Harshfield GA, Blank
S, Laragh JH. How common is white coat hypertension?
JAMA. 1988;259:225-228.
12.
Sahn DJ, DeMaria A, Kisslo J, Weymen A.
Recommendations regarding quantitation in M-mode
echocardiography: results of a survey of
echocardiographic measurements.
Circulation. 1978;58:1072-1083.
13. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, Silverman NH, Tajik AJ. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. Echocardiography. 1989;2:358-367.
14.
Devereux RB, Reichek N.
Echocardiographic determination of left
ventricular mass in man: anatomic validation of the
method. Circulation. 1977;55:613-618.
15. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in men and women with essential hypertension. Ann Intern Med. 1991;114:345-352.
16. Devereux RB, Lutas EM, Casale PN, Kligfield P, Eisenberg RR, Hammond IW, Miller DH, Reis G, Alderman MH, Laragh JH. Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol. 1984;4:1222-1230. [Abstract]
17.
Salonen R, Seppanen K, Ravramara R, Salonen JT.
Prevalence of carotid atherosclerosis and serum
cholesterol levels in Eastern Finland.
Arteriosclerosis. 1988;8:788-792.
18.
Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R.
Intimal plus medial thickness of the arterial wall:
a direct measurement with ultrasound imaging.
Circulation. 1986;74:1399-1406.
19.
Wikstrand J, Wiklund O. Quantitative
measurements of atherosclerotic manifestations in humans.
Arterioscler Thromb. 1992;12:114-119.
20.
Salonen JT, Salonen R. Association of serum low
density lipoprotein cholesterol, smoking and hypertension
with different manifestations of
atherosclerosis. Int J Epidemiol. 1990;19:911-917.
21.
Bonithon-Kopp C, Ducimetiere P, Touboul P-J, Feve J-M,
Billaud E, Courbon D, Heraud V. Plasma
angiotensin-converting enzyme activity and carotid wall
thickening. Circulation. 1994;89:952-954.
22. Dahlöf B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients: a metaanalysis of 109 treatment studies. Am J Hypertens. 1992;5:95-110. [Medline] [Order article via Infotrieve]
23.
Jula AM, Karanko HM. Effects on left
ventricular hypertrophy of long-term
nonpharmacologic treatment with sodium restriction in mild-to-moderate
essential hypertension. Circulation. 1994;89:1023-1031.
24.
Levy BI, Duriez M, Phillipe M, Poitevin P, Michel JB.
Effect of chronic dihydropyridine
(isradipine) on the large arterial walls of spontaneously
hypertensive rats. Circulation. 1994;90:3024-3033.
25. Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation. 1993;87(suppl II):II-56-II-65.
This article has been cited by other articles:
![]() |
K. Wachtell Left ventricular systolic performance in asymptomatic aortic stenosis Eur. Heart J. Suppl., July 1, 2008; 10(suppl_E): E16 - E22. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pini, M. C. Cavallini, V. Palmieri, N. Marchionni, M. Di Bari, R. B. Devereux, G. Masotti, and M. J. Roman Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: the ICARe Dicomano Study. J. Am. Coll. Cardiol., June 24, 2008; 51(25): 2432 - 2439. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Oyama, P. Gona, C. J. Salton, M. L. Chuang, R. R. Jhaveri, S. J. Blease, A. R. Manning, M. Lahiri, R. M. Botnar, D. Levy, et al. Differential Impact of Age, Sex, and Hypertension on Aortic Atherosclerosis: The Framingham Heart Study Arterioscler Thromb Vasc Biol, January 1, 2008; 28(1): 155 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J Roman, T. Z Naqvi, J. M Gardin, M. Gerhard-Herman, M. Jaff, and E. Mohler American Society of Echocardiography Report: Clinical application of noninvasive vascular ultrasound in cardiovascular risk stratification: a report from the American Society of Echocardiography and the Society for Vascular Medicine and Biology Vascular Medicine, August 1, 2006; 11(3): 201 - 211. [PDF] |
||||
![]() |
M. J. Roman, E. Moeller, A. Davis, S. A. Paget, M. K. Crow, M. D. Lockshin, L. Sammaritano, R. B. Devereux, J. E. Schwartz, D. M. Levine, et al. Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med, February 21, 2006; 144(4): 249 - 256. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Roman, R. B. Devereux, J. E. Schwartz, M. D. Lockshin, S. A. Paget, A. Davis, M. K. Crow, L. Sammaritano, D. M. Levine, B.-A. Shankar, et al. Arterial Stiffness in Chronic Inflammatory Diseases Hypertension, July 1, 2005; 46(1): 194 - 199. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Glorioso, F. Filigheddu, P. P. Parpaglia, A. Soro, C. Troffa, G. Argiolas, and P. Mulatero 11{beta}-Hydroxysteroid dehydrogenase type 2 activity is associated with left ventricular mass in essential hypertension Eur. Heart J., March 1, 2005; 26(5): 498 - 504. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Redberg, R. A. Vogel, M. H. Criqui, D. M. Herrington, J. A. C. Lima, and M. J. Roman Task force #3--what is the spectrum of current and emerging techniques for the noninvasive measurement of atherosclerosis? J. Am. Coll. Cardiol., June 4, 2003; 41(11): 1886 - 1898. [Full Text] [PDF] |
||||
![]() |
R. Pini, M. C. Cavallini, F. Bencini, G. Silvestrini, E. Tonon, W. De Alfieri, N. Marchionni, M. Di Bari, R. B. Devereux, G. Masotti, et al. Cardiovascular remodeling is greater in isolated systolic hypertension than in diastolic hypertension in older adults: the Insufficienza Cardiaca negli Anziani Residenti (ICARE) a Dicomano Study J. Am. Coll. Cardiol., October 2, 2002; 40(7): 1283 - 1289. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. North, J. W. MacCluer, R. B. Devereux, B. V. Howard, T. K. Welty, L. G. Best, E. T. Lee, R. R. Fabsitz, and M. J. Roman Heritability of Carotid Artery Structure and Function: The Strong Heart Family Study Arterioscler Thromb Vasc Biol, October 1, 2002; 22(10): 1698 - 1703. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pini, M. C. Cavallini, F. Bencini, L. Stagliano, E. Tonon, F. Innocenti, G. Baldereschi, N. Marchionni, M. Di Bari, R. B. Devereux, et al. Cardiac and Vascular Remodeling in Older Adults With Borderline Isolated Systolic Hypertension: The ICARe Dicomano Study Hypertension, December 1, 2001; 38(6): 1372 - 1376. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Palmieri, A. Celentano, M. J. Roman, G. de Simone, M. R. Lewis, L. Best, E. T. Lee, D. C. Robbins, B. V. Howard, and R. B. Devereux Fibrinogen and Preclinical Echocardiographic Target Organ Damage: The Strong Heart Study Hypertension, November 1, 2001; 38(5): 1068 - 1074. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Roman, T. G. Pickering, J. E. Schwartz, R. Pini, and R. B. Devereux Relation of Blood Pressure Variability to Carotid Atherosclerosis and Carotid Artery and Left Ventricular Hypertrophy Arterioscler Thromb Vasc Biol, September 1, 2001; 21(9): 1507 - 1511. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Roman, A. Ganau, P. S. Saba, R. Pini, T. G. Pickering, and R. B. Devereux Impact of Arterial Stiffening on Left Ventricular Structure Hypertension, October 1, 2000; 36(4): 489 - 494. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Saba, M. J. Roman, C. Longhini, D. Scorzoni, R. Pini, R. B. Devereux, and A. Ganau Carotid Intimal-Medial Thickness and Stiffness Are Not Affected by Hypercholesterolemia in Uncomplicated Essential Hypertension Arterioscler Thromb Vasc Biol, November 1, 1999; 19(11): 2788 - 2794. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Palmieri, G. de Simone, M. J. Roman, J. E. Schwartz, T. G. Pickering, and R. B. Devereux Ambulatory Blood Pressure and M;etabolic Abnormalities in Hypertensive Subjects With Inappropriately High Left Ventricular Mass Hypertension, November 1, 1999; 34(5): 1032 - 1040. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Djuric, Z. Popovic, J. Petrovic, M. Bojic, and D. M. Djuric Age-Related Progressive Brachial Artery Endothelial Dysfunction Precedes the Changed Carotid and Left Ventricular Geometry in Healthy Humans Angiology, July 1, 1999; 50(7): 555 - 561. [Abstract] [PDF] |
||||
![]() |
F. Perticone, R. Maio, R. Ceravolo, C. Cosco, C. Cloro, and P. L. Mattioli Relationship Between Left Ventricular Mass and Endothelium-Dependent Vasodilation in Never-Treated Hypertensive Patients Circulation, April 20, 1999; 99(15): 1991 - 1996. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Bella, M. J. Roman, R. Pini, J. E. Schwartz, T. G. Pickering, and R. B. Devereux Assessment of Arterial Compliance by Carotid Midwall Strain-Stress Relation in Normotensive Adults Hypertension, March 1, 1999; 33(3): 787 - 792. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Bella, M. J. Roman, R. Pini, J. E. Schwartz, T. G. Pickering, and R. B. Devereux Assessment of Arterial Compliance by Carotid Midwall Strain-Stress Relation in Hypertension Hypertension, March 1, 1999; 33(3): 793 - 799. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Rizzoni, M. L. Muiesan, E. Porteri, M. Salvetti, M. Castellano, G. Bettoni, G. Tiberio, S. M. Giulini, C. Monteduro, G. Garavelli, et al. Relations between cardiac and vascular structure in patients with primary and secondary hypertension J. Am. Coll. Cardiol., October 1, 1998; 32(4): 985 - 992. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Chen, C.-T. Ting, S.-J. Lin, T.-L. Hsu, S.-J. Ho, P. Chou, M.-S. Chang, F. O'Connor, H. Spurgeon, E. Lakatta, et al. Which Arterial and Cardiac Parameters Best Predict Left Ventricular Mass? Circulation, August 4, 1998; 98(5): 422 - 428. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Okin, M. J. Roman, J. E. Schwartz, T. G. Pickering, and R. B. Devereux Relation of Exercise-Induced Myocardial Ischemia to Cardiac and Carotid Structure Hypertension, December 1, 1997; 30(6): 1382 - 1388. [Abstract] [Full Text] |
||||
![]() |
G. de Simone Mary J. Roman Stephen R. Daniels GianFra Age-Related Changes in Total Arterial Capacitance From Birth to Maturity in a Normotensive Population Hypertension, June 1, 1997; 29(6): 1213 - 1217. [Abstract] [Full Text] |
||||
![]() |
S. Sharma, A. Naqvi, S. M. Sharma, A. F. Cruess, G. C. Brown, and Retinal Emboli of Cardiac Origin Group Transthoracic Echocardiographic Findings in Patients With Acute Retinal Arterial Obstruction: A Retrospective Review Arch Ophthalmol, October 1, 1996; 114(10): 1189 - 1192. [Abstract] [PDF] |
||||
![]() |
M. L. Muiesan, G. Pasini, M. Salvetti, S. Calebich, R. Zulli, M. Castellano, D. Rizzoni, G. Bettoni, A. Cinelli, E. Porteri, et al. Cardiac and Vascular Structural Changes : Prevalence and Relation to Ambulatory Blood Pressure in a Middle-aged General Population in Northern Italy: The Vobarno Study Hypertension, May 1, 1996; 27(5): 1046 - 1052. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |